Spleens of triple therapy animals showed significantly more CD8 + cells, with non-significant increases in CD4 + and MHC-II + also present, supportive of generation of systemic anti-cancer immunity following chemotherapy, ICI and virotherapy (Fig. 5G). The gene discussed is CD8A; the disease is cancer.